NEXGEL, INC. Deferred State and Local Income Tax Expense (Benefit)
NEXGEL, INC. (NXGL) reported Deferred State and Local Income Tax Expense (Benefit) of $104.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-31
- NEXGEL, INC. deferred state and local income tax expense (benefit) for fiscal 2025 was $104.00K, a 35.40% decline from fiscal 2024.
- NEXGEL, INC. deferred state and local income tax expense (benefit) for fiscal 2024 was $161.00K, a 3.21% increase from fiscal 2023.
- NEXGEL, INC. deferred state and local income tax expense (benefit) for fiscal 2023 was $156.00K, a 1.89% decline from fiscal 2022.
- NEXGEL, INC. deferred state and local income tax expense (benefit) for fiscal 2022 was $159.00K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $104.00K 10-K · filed 2026-03-31 |
| 2024-12-31 | $161.00K 10-K · filed 2026-03-31 |
| 2023-12-31 | $156.00K 10-K · filed 2025-03-27 |
| 2022-12-31 | $159.00K 10-K · filed 2024-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |